Company

Youngene Therapeutics

As of the edition of 20 October 2026, Youngene Therapeutics runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Hormones: 3 trials led
  • Nutrition and metabolism: 3 trials led
  • Immune system: 1 trials led